Compare CVGI & INCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CVGI | INCR |
|---|---|---|
| Founded | 2000 | 1994 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Auto Parts:O.E.M. | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 59.5M | 50.4M |
| IPO Year | 2004 | 2021 |
| Metric | CVGI | INCR |
|---|---|---|
| Price | $1.51 | $0.85 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 128.5K | 45.7K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 316.18 | N/A |
| EPS | ★ 0.04 | N/A |
| Revenue | ★ $755,231,000.00 | N/A |
| Revenue This Year | N/A | $69.54 |
| Revenue Next Year | N/A | $41.75 |
| P/E Ratio | $39.50 | ★ N/A |
| Revenue Growth | ★ 14.06 | N/A |
| 52 Week Low | $0.81 | $0.68 |
| 52 Week High | $2.10 | $1.77 |
| Indicator | CVGI | INCR |
|---|---|---|
| Relative Strength Index (RSI) | 41.42 | 43.37 |
| Support Level | $1.46 | $0.76 |
| Resistance Level | $1.85 | $0.98 |
| Average True Range (ATR) | 0.11 | 0.05 |
| MACD | -0.02 | 0.01 |
| Stochastic Oscillator | 15.79 | 63.90 |
Commercial Vehicle Group Inc is a provider of systems, assemblies, and components to the commercial vehicle market and the electric vehicle markets. It delivers solutions to complex design, engineering, and manufacturing problems while creating positive change for customers, industries, and communities. Its operating segments are Vehicle Solutions, Electrical Systems, and Aftermarket and Accessories. The company makes the majority of its revenue from Vehicle Solutions. The group generates revenue from its products including seating systems, plastic components, electrical wire harnesses, mirrors, wipers, and other accessories. Its geographic regions are North America, Europe and Asia-Pacific.
Intercure Ltd is engaged in the research, cultivation, production, and distribution of pharma-grade cannabis-based products. Its products are available in dried inflorescences or liquid oil form, and are marketed through various brands, including Pharmo Cann, Humboldt, Indoor, Space Labs, Canndoc Utopia, Binske, Canndoc Stars, and others. The company has two operating segments, namely Investments in portfolio companies in the biomed sector and Investments in the medical cannabis sector. A majority of its revenue is generated from the Cannabis segment.